Skip to Main Content

Paper Details

Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma.
Cancer Cell
65
2017
H4K20me1 methyltransferase, High-Risk Neuroblastoma, NB, NB cell, SETD8, UNC0379, chromatin, genes, high-risk NB, neuroblastoma, p53, p53K382me1, small interfering RNA, xenograft
Author NameAffiliation
Ty C VossCenter for Cancer Research, National Cancer Institute
Ty C VossCenter for Cancer Research, National Cancer Institute
Jian JinIcahn School of Medicine at Mount Sinai
Gordon L HagerCenter for Cancer Research, National Institutes of Health
Gordon L HagerCenter for Cancer Research, National Institutes of Health
Cheryl H ArrowsmithUniversity of Toronto
Javed KhanCenter for Cancer Research, National Cancer Institute
Javed KhanCenter for Cancer Research, National Cancer Institute
Ettore AppellaNational Cancer Institute
  • 1 - 9

Datasets

Release 1.2